1984
DOI: 10.3758/bf03332184
|View full text |Cite
|
Sign up to set email alerts
|

Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat

Abstract: For 3 days, rats received daily bilateral microinjections of d-amphetamine or saline into either the nucleus accumbens or the caudate putamen. On Days 1 and 3, each animal was tested for stereotypy and locomotion (number of grid crossings). Microinjections of d-amphetamine into the nucleus accumbens but not the caudate putamen produced an increase in locomotion but had no effect on stereotypy, whereas d-amphetamine microinjections into the caudate-putamen but not the nucleus accumbens produced an increase in s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
57
0

Year Published

1988
1988
2013
2013

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 154 publications
(57 citation statements)
references
References 19 publications
(20 reference statements)
0
57
0
Order By: Relevance
“…Originally, we expected that performance would deteriorate under a DA agonist given that (1) DA agonists can worsen psychotic symptoms in patients with schizophrenia (Davidson et al, 1987;Abi-Dargham et al, 1998) and trigger psychotic symptoms in healthy participants (Janowsky and Risch, 1979;Sekine et al, 2001); (2) schizotypy and schizophrenia share cognitive (Gooding et al, 1999;Park, 1999), attentional (Sarkin et al, 1998;Mohr et al, 2003a), behavioral (Barnett and Corballis, 2002;Mohr et al, 2003b), and physiological (Klein et al, 1999;Pizzagalli et al, 2000) similarities; and (3) DA agonists increase stereotyped responding in animals (Randrup and Munkvad, 1974;Staton and Solomon, 1984;Kelley et al, 1988) and healthy populations (Connell, 1958;Ridley et al, 1988). Findings from animal (Arnsten, 1997;Williams and Goldman-Rakic, 1995) and human (Mehta et al, 2000) studies propose that dopaminergic actions follow an inverted Ushape function, with an improvement of cognitive performance from low to medium, but deterioration from medium to high doses.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Originally, we expected that performance would deteriorate under a DA agonist given that (1) DA agonists can worsen psychotic symptoms in patients with schizophrenia (Davidson et al, 1987;Abi-Dargham et al, 1998) and trigger psychotic symptoms in healthy participants (Janowsky and Risch, 1979;Sekine et al, 2001); (2) schizotypy and schizophrenia share cognitive (Gooding et al, 1999;Park, 1999), attentional (Sarkin et al, 1998;Mohr et al, 2003a), behavioral (Barnett and Corballis, 2002;Mohr et al, 2003b), and physiological (Klein et al, 1999;Pizzagalli et al, 2000) similarities; and (3) DA agonists increase stereotyped responding in animals (Randrup and Munkvad, 1974;Staton and Solomon, 1984;Kelley et al, 1988) and healthy populations (Connell, 1958;Ridley et al, 1988). Findings from animal (Arnsten, 1997;Williams and Goldman-Rakic, 1995) and human (Mehta et al, 2000) studies propose that dopaminergic actions follow an inverted Ushape function, with an improvement of cognitive performance from low to medium, but deterioration from medium to high doses.…”
Section: Discussionmentioning
confidence: 99%
“…As known from the animal literature, the administration of DA agonists can trigger stereotyped behavior (Staton and Solomon, 1984;Kelley et al, 1988;Kuczenski and Segal, 1999), particularly after high doses (Randrup and Munkvad, 1974). It is thus not a surprise that stereotyped behavior is observed in patients with schizophrenia (Kraeplin, 1919;Bleuler, 1911Bleuler, / 1950Jones, 1965;Peralta and Cuesta, 2001) and in healthy persons after amphetamine abuse (Connell, 1958, Ridley et al, 1988.…”
Section: Introductionmentioning
confidence: 99%
“…This suggests that DA in NAc mediates hyperlocomotion, whereas DA in the dorsal striatum mediates stereotypies. In fact selective injections of amphetamine within the NAc [103] as well as in the ventrolateral striatum [104] induce hyper-locomotion, whereas injections in the dorsal striatum produce stereotypies [104-106]. …”
Section: Methamphetamine-induced Behavioural Effectsmentioning
confidence: 99%
“…Such a biphasic profile is not surprising. Indeed, following repeated administration of high AMPH dosages, adult rodents usually exhibit sensitization of stereotyped behavioral activity (Staton and Solomon 1984;Stewart and Badiani 1993). It can be hypothesized that the excessive arousal, repeatedly induced by high AMPH dosages during the pretreatment phase, might have produced, together with observable stereotypies, unobservable aversive effects ("poor welfare," see Laviola et al 1994Laviola et al , 1995Laviola and Adriani 1998), which were associated with the drug-paired compartment.…”
Section: Amph-induced Place Conditioningmentioning
confidence: 99%